TB-500

TB-500 is a synthetic peptide fragment of thymosin beta-4, a naturally occurring protein involved in tissue repair and regeneration.
It has been studied primarily in animal models for its ability to promote cell migration, angiogenesis, and wound healing.
TB-500 is distinct from full thymosin beta-4 in that it represents the active region responsible for many of the regenerative effects.
It remains experimental and is not FDA-approved for therapeutic use.

How It Is Used in Research Settings

• Investigated for promoting wound healing and tissue regeneration through actin regulation and cell migration.
• Studied for its ability to stimulate angiogenesis, supporting blood vessel growth in injured tissues.
• Explored in musculoskeletal research for recovery of muscle, tendon, and ligament injuries.
• Examined in cardiac and vascular studies for potential repair of heart and vascular tissue.

Proposed Uses (Research Areas)

• Muscle, tendon, and ligament healing studies.
• Wound and burn healing models.
• Cardiac repair research, including ischemic injury recovery.
• Vascular health and angiogenesis studies.
• Fibrosis and scar tissue reduction models.

How It Is Dosed in Research Settings

• Injectable: 2–5 mg administered subcutaneously or intramuscularly, typically twice weekly.
• Cycle length: Research protocols often span 4–6 weeks of twice-weekly administration, followed by monthly maintenance doses.
• Combination protocols: Sometimes paired with BPC-157 in research for complementary localized and systemic healing effects.
• Handling: Reconstituted with bacteriostatic water and stored refrigerated per research SOPs.

Important Considerations

• Regulatory status: TB-500 is not FDA-approved; all applications remain experimental.
• Evidence base: Most data is from animal and cell culture studies; human clinical trials are limited.
• Safety: Preclinical data suggests low toxicity, but human safety profile is not established. Quality and purity of sourcing are important.

Disclaimer

This material is provided for educational purposes only and summarizes published research on TB-500.
It is not medical advice. TB-500 is experimental, not FDA-approved, and should not be viewed as a therapy for medical use.

This peptide is for research use only.